GAEX yields 20000000.00% · JNJ yields 2.13%● Live data
📍 GAEX pulled ahead of the other in Year 1
Combined, GAEX + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GAEX + JNJ for your $10,000?
GA eXpress, Inc. engages in the development and licensing of computer software and related software-consulting services. The company's primary products offer data connectivity that enables businesses to connect legacy applications and databases to e-business exchanges and trading partners over the Internet. It has developed a portfolio of software products and services under the name of ePath. The ePath products include a suite of middleware, eTools that are focused on data access and connectivity for the MultiValue marketplace, and a collaborative commerce server, code named Selva Server. The company's professional services include consulting services, training-related services to customers and partners, and software maintenance services, including technical support. GA eXpress has subsidiaries in the United States, Canada, Australia, and United Kingdom. The company, formerly known as General Automation, Inc., is based in Vancouver, Canada.
Full GAEX Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.